NanoString Technologies nCounter Vantage 3D Assay portfolio powered by 3D Biology Technology

Wednesday, 24 May, 2017 | Supplied by: Bio-Strategy Pty Ltd



3D Biology Technology is the ability to analyse combinations of DNA, RNA and protein simultaneously in a single experiment. NanoString Technologies is pioneering this digital molecule-counting technology to accelerate research and maximise the amount of information that can be generated from a given sample.

The nCounter Vantage 3D Assay portfolio is powered by 3D Biology Technology, enabling users to profile various combinations of DNA, RNA and protein targets up to 800-plex from a single sample. Designed for flexibility, users can select the right panel for each analyte type and profile all three at once with the nCounter Analysis System and free nSolver software. Multi-analyte prematched assays are available to simplify users’ selection and provide curated content for specific research areas, including immuno-oncology, solid tumour and lung tumour profiling.

Online: www.bio-strategy.com
Phone: 1800 00 84 53
Related Products

Enzo Life Sciences PKA kinase activity kit

Enzo Life Sciences' PKA kinase activity kit is a safe, rapid method for screening of...

AdipoGen Life Sciences BioStab PCR Optimizer

The product is designed as a PCR additive that improves the yield and specificity of the PCR...

Cayman Chemical cGAS Inhibitor Screening Assay Kit

Cayman Chemical's cGAS Inhibitor Screening Assay Kit provides a robust and easy-to-use...


  • All content Copyright © 2021 Westwick-Farrow Pty Ltd